Download ProteinsSynthesisInh..

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Protein Synthesis Inhibitors
Tetracyclines
Macrolides
Chloramphenicol
Aminoglycosides
Clindamycin
Streptogramins
Alan M. Reynared, Ph.D.
QUICK REVIEW - Protein Synthesis
Tetracyclines - Structure
Excretion
R1 R2 R3
tetracycline (Achromycin)
H OH CH3
chlortetracycline (Aureomycin)
H OH CH3
oxytetracycline (Terramycin)
OH OH CH3
demethylchlortetracycline (Declomycin)
H OH H
doxycycline (Vibramycin)
minocycline (Minocin)
OH
H
CH3
H
R4 mg/hr
H
65
Cl
32
H
90
Cl
35
H
H
16
H N(CH3) 9
Tetracyclines - Uses
Gram- Bacteria
 Helicobacter pylori (duodenal ulcer)
 Borrelia recurrentis (Lyme disease, relapsing fever)
Other Organisms
 Mycoplasma pneumoniae
 acne
Tetracycline - Mechanism
 Inhibits protein synthesis
 Static
 Chelates divalent cations -- Ca++, Mg++
Tetracycline - Adverse Effects
 headache, nausea, vomiting
 discoloration of bones and teeth
 photosensitivity
 liver damage
 superinfection
Superinfection
A new infection appearing during treatment
for a primary infection
The organism will be resistant to the antibiotic
used for the primary infection
Organisms causing superinfection
Staphylococcus aureus - enterocolitis
Candida albicans - vagina, mouth
Clostridium difficile - pseudomembranous colitis
Risk factors
in hospital > 6 days
6 > age > 60
broad spectrum antibiotic
Tetracylines
 Administration
Oral administration but interference by
food, Ca++, Mg++
 Excretion
renal, fecal enterohepatic
Chloramphenicol - structure/features
Features
 Broad Spectrum
 Inexpensive
 Oral administration
 Virtually non-toxic
Chloramphenicol - uses/toxicity
Uses
 Haemophilus influenzae (meningitis)
 Typhus
 Rocky Mountain Spotted Fever
 eye infections
Adverse Effects
 superinfection
 aplastic anemia
Chloramphenicol - mechanism
 Inhibits protein synthesis
 Static
Macrolides - structure / names
erythromycin
azithromycin
clarithromycin
Macrolides - uses
whooping cough
pharyngitis
Community-acquired pneumonia
Penicillin-allergic patients
staphylococcus
streptococcus
pneumococcus
Macrolides - mechanism
 Inhibits protein synthesis
 Static
Macrolides - toxicity / drug interactions
Toxicity
 nausea, vomiting, diarrhea
 cholestatic hepatitis (esp. estolate)
Drug Interactions
 inhibit P450 system
Macrolides
Administration
 erythromycin destroyed by gastric acid
- enteric coated tablets
- erythromycin stearate
- erythromycin estolate
 food decreases absorption of all macrolides
Aminoglycosides - structure / names
streptomycin
kanamycin
neomycin
paromomycin
gentamicin
tobramycin
netilmicin
amikacin
spectinomycin
Aminoglycosides - uses
Amikacin
 serious Gram-negative infections
 endocarditis (+ a penicillin or cephalosporin)
Streptomycin
 plague (Yersinia pestis)
 tuleremia (Francisella tulerensis)
 tuberculosis (Mycobacterium tuberculosis)
Aminoglycosides - mechanism
 inhibits protein synthesis
 ribosomal binding is very tight
 cidal
 at high doses  bacterial cell permeability
Aminglycosides - adverse effects
- deafness
- vertigo
- kidney damage
Aminoglycosides - spectinomycin
Use
Reserve drug for gonorrhea
Clindamycin
USES
 Staphylococcus aureus
 Streptococcus pyogenes
 Bacteroides fragilis
 Clostridium tetani
Clindamycin - mechanism
 Inhibits protein synthesis
 static
Clindamycin - adverse effects
superinfection
pseudomembranous colitis
(ulcerative colitis)
Clostridium difficile
Streptogramins
Synercid
 synergistic combination
quinupristin
dalfopristin
 activity against
staphylococci
streptococci
vancomycin-resistant enterococci (VRE)
Drug Resistance
Types of resistance
chromosomal
plasmid-mediated
Mechanisms of resistance
enzymatic destruction of drug
altered target of drug
decreased influx of drug
increased efflux of drug
Drug Resistance
1955 - epidemic of dysentary in Tokyo
Multiple Drug Resistance
tetracycline
10-8
10-8
chloramphenicol
10-8
sulfisoxazole
10-8
streptomycin
all four
10-32
Transmissible Drug Resistance
patient excreting MDR S. dysenteriae and E. coli
Drug Resistance
Bacterial Conjugation
Drug Resistance
Plasmid specifying resistance to 2 antibiotics
Drug Resistance
MDR spread rapidly all over the world
Drug Resistance
Increase in resistance
with increased
production of antibiotics
Drug Resistance - specific antibiotics
penicillin
-lactamase
altered penicillin-binding protein
aminoglycosides
acetylation
AcCoA + AG
phosphorylation
ATP + AG
adenylylation
ATP + AG
AcAG + CoA
P-Ag + ADP
AMP-Ag + PPi
Drug Resistance - specific antibiotics
chloramphenicol
acetylation
AcCoA + CM
erythromycin
altered ribosome
tetracycline
active efflux of drug
AcCM + CoA
Drug Resistance - aminoglycosides
Sulfonamides
Gerhard Domagk, 1895 - 1964
V.P., I. G. Farbenindustrie
Related documents